Development of selective agonist to potentiate BMP signaling pathway in L cells would be a novel therapeutic strategy to potentiate GLP-1 secretion, leading to restored glycemic homeostasis in T2D patients. Here, GLP1R is linked to type 2 diabetes mellitus.